PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.07 and traded as high as $0.10. PURE Bioscience shares last traded at $0.10, with a volume of 141,738 shares traded.
PURE Bioscience Stock Performance
The stock has a fifty day moving average of $0.07 and a 200 day moving average of $0.07. The company has a market capitalization of $11.19 million, a PE ratio of -2.50 and a beta of 0.39.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its quarterly earnings results on Monday, March 17th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.39 million during the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Read More
- Five stocks we like better than PURE Bioscience
- Want to Profit on the Downtrend? Downtrends, Explained.
- Among the Market’s Most Shorted: 2 Firms With +40% Short Interest
- Bank Stocks – Best Bank Stocks to Invest In
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- 3 Stocks to Consider Buying in October
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
